AMBU N Stock Overview
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Ambu A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.697.47 |
| 52 Week High | kr.0 |
| 52 Week Low | kr.0 |
| Beta | 0.63 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | -1.80% |
| 5 Year Change | n/a |
| Change since IPO | 57.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| AMBU N | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | 0% | 0% | 0% |
Return vs Industry: AMBU N exceeded the MX Medical Equipment industry which returned -2.1% over the past year.
Return vs Market: AMBU N underperformed the MX Market which returned 3.7% over the past year.
Price Volatility
| AMBU N volatility | |
|---|---|
| AMBU N Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: AMBU N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AMBU N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 4,500 | Britt Jensen | www.ambu.com |
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Ambu A/S Fundamentals Summary
| AMBU N fundamental statistics | |
|---|---|
| Market cap | Mex$70.30b |
| Earnings (TTM) | -Mex$162.13m |
| Revenue (TTM) | Mex$11.50b |
6.1x
P/S Ratio-433.6x
P/E RatioIs AMBU N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMBU N income statement (TTM) | |
|---|---|
| Revenue | kr.4.61b |
| Cost of Revenue | kr.2.01b |
| Gross Profit | kr.2.60b |
| Other Expenses | kr.2.66b |
| Earnings | -kr.65.00m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Aug 31, 2023
| Earnings per share (EPS) | -0.24 |
| Gross Margin | 56.35% |
| Net Profit Margin | -1.41% |
| Debt/Equity Ratio | 6.5% |
How did AMBU N perform over the long term?
See historical performance and comparison